Edmond De Rothschild Holding S.A. Astrazeneca PLC Transaction History

Edmond De Rothschild Holding S.A.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$61.89 - $69.28 $475,934 - $532,763	7,690 Added 17.18%	52,457 $3.53 Million
Q3 2023 Nov 13, 2023	BUY	$64.85 - $71.7 $132,358 - $146,339	2,041 Added 4.78%	44,767 $3.03 Million
Q2 2023 Aug 09, 2023	BUY	$69.91 - $75.81 $368,006 - $399,063	5,264 Added 14.05%	42,726 $3.06 Million
Q1 2023 May 11, 2023	BUY	$63.15 - $71.6 $148,023 - $167,830	2,344 Added 6.67%	37,462 $2.6 Million
Q4 2022 Feb 09, 2023	BUY	$54.21 - $70.44 $117,852 - $153,136	2,174 Added 6.6%	35,118 $2.38 Million
Q3 2022 Nov 09, 2022	SELL	$53.02 - $135.75 $227,084 - $581,417	-4,283 Reduced 11.51%	32,944 $1.81 Million
Q2 2022 Aug 12, 2022	BUY	$59.26 - $71.14 $562,258 - $674,976	9,488 Added 34.2%	37,227 $2.46 Million
Q1 2022 May 10, 2022	BUY	$55.72 - $67.12 $1.55 Million - $1.86 Million	27,739 New	27,739 $1.84 Million

1,343

492M

4.99M

3.19M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $233B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Edmond De Rothschild Holding S.A., based on Form 13F filings with the SEC.

Stay updated on Edmond De Rothschild Holding S.A. with notifications on news.